The Inhibitory Effect of Curosurf and Alveofact on the Formation of Neutrophil Extracellular Traps

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2021 Feb 12

PMID 33574811

Citations 8

Authors

Annabell Schulz

Laia Pagerols Raluy

Jan Philipp Kolman

Ingo Konigs

Magdalena Trochimiuk

Birgit Appl

Konrad Reinshagen

Michael Boettcher

Julian Trah

Affiliations

Soon will be listed here.

Abstract

Background: Neutrophil extracellular traps (NETs) are a defense mechanism in which neutrophils cast a net-like structure in response to microbial infection. NETs consist of decondensed chromatin and about 30 enzymes and peptides. Some components, such as neutrophil elastase (NE) and myeloperoxidase (MPO), present antimicrobial but also cytotoxic properties, leading to tissue injury. Many inflammatory diseases are associated with NETs, and their final role has not been identified. Pulmonary surfactant is known to have immunoregulatory abilities that alter the function of adaptive and innate immune cells. The aim of this study was to investigate the hypothesis that natural surfactant preparations inhibit the formation of NETs.

Methods: The effect of two natural surfactants (Alveofact and Curosurf) on spontaneous and phorbol-12-myristate-13-acetate-induced NET formation by neutrophils isolated by magnetic cell sorting from healthy individuals was examined. NETs were quantitatively detected by absorption and fluorometric-based assays for the NET-specific proteins (NE, MPO) and cell-free DNA. Immunofluorescence microscopy images were used for visualization.

Results: Both surfactant preparations exerted a dose-dependent inhibitory effect on NET formation. Samples treated with higher concentrations and with 30 min pre-incubation prior to stimulation with phorbol-12-myristate-13-acetate had significantly lower levels of NET-specific proteins and cell-free DNA compared to untreated samples. Immunofluorescence microscopy confirmed these findings.

Conclusions: The described dose-dependent modulation of NET formation ex vivo suggests an interaction between exogenous surfactant supplementation and neutrophil granulocytes. The immunoregulatory effects of surfactant preparations should be considered for further examination of inflammatory diseases.

Citing Articles

Neutrophil extracellular traps in homeostasis and disease.

Wang H, Kim S, Lei Y, Wang S, Wang H, Huang H Signal Transduct Target Ther. 2024; 9(1):235.

PMID: 39300084 PMC: 11415080. DOI: 10.1038/s41392-024-01933-x.

Exposure to Aldehyde Cherry e-Liquid Flavoring and Its Vaping Byproduct Disrupt Pulmonary Surfactant Biophysical Function.

Martin A, Tempra C, Yu Y, Liekkinen J, Thakker R, Lee H Environ Sci Technol. 2024; 58(3):1495-1508.

PMID: 38186267 PMC: 10809783. DOI: 10.1021/acs.est.3c07874.

In Vitro Dissolution and Permeability Testing of Inhalation Products: Challenges and Advances.

Nokhodchi A, Chavan S, Ghafourian T Pharmaceutics. 2023; 15(3).

PMID: 36986844 PMC: 10059005. DOI: 10.3390/pharmaceutics15030983.

(+)-Borneol inhibits the generation of reactive oxygen species and neutrophil extracellular traps induced by phorbol-12-myristate-13-acetate.

Chen H, Xu X, Tang Q, Ni L, Cao S, Hao Y Front Pharmacol. 2022; 13:1023450.

PMID: 36419617 PMC: 9676272. DOI: 10.3389/fphar.2022.1023450.

Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress.

Yalaz M, Tanriverdi S, Uygur O, Altun Koroglu O, Azarsiz E, Aksu G Front Pediatr. 2022; 10:845780.

PMID: 35372166 PMC: 8971705. DOI: 10.3389/fped.2022.845780.

References

Glasser S, Senft A, Whitsett J, Maxfield M, Ross G, Richardson T . Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice. J Immunol. 2008; 181(1):621-8. PMC: 4344318. DOI: 10.4049/jimmunol.181.1.621. View

Demaurex N, Nunes P . The role of STIM and ORAI proteins in phagocytic immune cells. Am J Physiol Cell Physiol. 2016; 310(7):C496-508. PMC: 4824159. DOI: 10.1152/ajpcell.00360.2015. View

Saffarzadeh M, Juenemann C, Queisser M, Lochnit G, Barreto G, Galuska S . Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One. 2012; 7(2):e32366. PMC: 3289648. DOI: 10.1371/journal.pone.0032366. View

Baroutis G, Kaleyias J, Liarou T, Papathoma E, Hatzistamatiou Z, Costalos C . Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr. 2003; 162(7-8):476-480. DOI: 10.1007/s00431-002-1144-0. View

Ikegami M, Scoville E, Grant S, Korfhagen T, Brondyk W, Scheule R . Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation. Chest. 2007; 132(5):1447-54. DOI: 10.1378/chest.07-0864. View

Henderson L, Chappell J . Dihydrorhodamine 123: a fluorescent probe for superoxide generation?. Eur J Biochem. 1993; 217(3):973-80. DOI: 10.1111/j.1432-1033.1993.tb18328.x. View

Mulugeta S, Beers M . Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. Microbes Infect. 2006; 8(8):2317-23. DOI: 10.1016/j.micinf.2006.04.009. View

Garcia-Verdugo I, de Paco E, Espinassous Q, Gonzalez-Horta A, Synguelakis M, Kanellopoulos J . Synthetic peptides representing the N-terminal segment of surfactant protein C modulate LPS-stimulated TNF-alpha production by macrophages. Innate Immun. 2009; 15(1):53-62. DOI: 10.1177/1753425908100500. View

Melton K, Nesslein L, Ikegami M, Tichelaar J, Clark J, Whitsett J . SP-B deficiency causes respiratory failure in adult mice. Am J Physiol Lung Cell Mol Physiol. 2003; 285(3):L543-9. DOI: 10.1152/ajplung.00011.2003. View

10.

Fuchs T, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V . Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007; 176(2):231-41. PMC: 2063942. DOI: 10.1083/jcb.200606027. View

11.

Wright J . Immunomodulatory functions of surfactant. Physiol Rev. 1997; 77(4):931-62. DOI: 10.1152/physrev.1997.77.4.931. View

12.

Madsen J, Kliem A, Tornoe I, Skjodt K, Koch C, Holmskov U . Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol. 2000; 164(11):5866-70. DOI: 10.4049/jimmunol.164.11.5866. View

13.

Nemeth T, Sperandio M, Mocsai A . Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov. 2020; 19(4):253-275. DOI: 10.1038/s41573-019-0054-z. View

14.

Arroyo R, Khan M, Echaide M, Perez-Gil J, Palaniyar N . SP-D attenuates LPS-induced formation of human neutrophil extracellular traps (NETs), protecting pulmonary surfactant inactivation by NETs. Commun Biol. 2019; 2:470. PMC: 6915734. DOI: 10.1038/s42003-019-0662-5. View

15.

Kuronuma K, Mitsuzawa H, Takeda K, Nishitani C, Chan E, Kuroki Y . Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J Biol Chem. 2009; 284(38):25488-500. PMC: 2757950. DOI: 10.1074/jbc.M109.040832. View

16.

Wright J . Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005; 5(1):58-68. DOI: 10.1038/nri1528. View

17.

Chroneos Z, Sever-Chroneos Z, Shepherd V . Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem. 2010; 25(1):13-26. PMC: 3025886. DOI: 10.1159/000272047. View

18.

Balaiya S, Chalam K . An Assay to Quantify Nitrosative Component of Oxidative Stress. J Mol Genet Med. 2016; 8(3). PMC: 4712929. DOI: 10.4172/1747-0862.1000120. View

19.

Levine A, Kurak K, Bruno M, Stark J, Whitsett J, Korfhagen T . Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol. 1998; 19(4):700-8. DOI: 10.1165/ajrcmb.19.4.3254. View

20.

Yang L, Johansson J, Ridsdale R, Willander H, Fitzen M, Akinbi H . Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH. J Immunol. 2009; 184(2):975-83. PMC: 2803329. DOI: 10.4049/jimmunol.0900650. View